Literature DB >> 15981690

Clinical and surface EMG characteristics of valproate induced tremors.

M M Mehndiratta1, M Satyawani, S Gupta, G A Khwaja.   

Abstract

PURPOSE: To describe the Clinical and Surface EMG characteristics of Valproate induced Tremors. Sodium Valproate is known to produce tremors as a side effect. We analyzed clinical and surface electromyographic characteristics of tremors in epileptic subjects who presented with tremors while on sodium valproate.
METHODS: Neurological examination and surface electromyographic recordings were performed on 20 subjects with sodium valproate induced tremors. Surface electromyographic tremerogram was correlated with clinical presentation of tremors.
RESULTS: This study revealed sodium valproate induced tremors involving primarily upper limbs symmetrically. In the present study, all patients presented with action postural tremors except two, who had tremors in the resting position as well. None of these patients had tremors in goal-directed position. The tremors typically were of high frequency (mean 10 Hz), low amplitude, short burst duration and synchronous burst pattern (Synchronous EMG activity in the agonist and antagonistic muscles).
CONCLUSIONS: Frequency, amplitude, burst duration and burst pattern of sodium valproate induced tremors resembles benign essential tremors on surface electromyographic recordings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981690

Source DB:  PubMed          Journal:  Electromyogr Clin Neurophysiol        ISSN: 0301-150X


  6 in total

1.  SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy.

Authors:  Alberto Bergareche; Marcin Bednarz; Elena Sánchez; Catharine E Krebs; Javier Ruiz-Martinez; Patricia De La Riva; Vladimir Makarov; Ana Gorostidi; Karin Jurkat-Rott; Jose Felix Marti-Masso; Coro Paisán-Ruiz
Journal:  Hum Mol Genet       Date:  2015-10-01       Impact factor: 6.150

2.  Investigation of the risk of valproic acid-induced tremor: clinical, neuroimaging, and genetic factors.

Authors:  Lili Lan; Xu Zhao; Si Jian; Cun Li; Man Wang; Qing Zhou; Shanshan Huang; Suiqiang Zhu; Huicong Kang; Heidi E Kirsch
Journal:  Psychopharmacology (Berl)       Date:  2021-10-30       Impact factor: 4.530

Review 3.  Antiseizure Drugs and Movement Disorders.

Authors:  Michel Sáenz-Farret; Marina A J Tijssen; Dawn Eliashiv; Robert S Fisher; Kapil Sethi; Alfonso Fasano
Journal:  CNS Drugs       Date:  2022-07-21       Impact factor: 6.497

4.  Tremor and Klinefelter's Syndrome.

Authors:  Marcie L Rabin; Shivam Om Mittal; Bahman Jabbari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-06-15

Review 5.  Insights into Pathophysiology from Medication-induced Tremor.

Authors:  John C Morgan; Julie A Kurek; Jennie L Davis; Kapil D Sethi
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2017-11-22

6.  Clinical and Kinematic Features of Valproate-Induced Tremor and Differences with Essential Tremor.

Authors:  Giulia Paparella; Luca Angelini; Alessandro De Biase; Antonio Cannavacciuolo; Donato Colella; Carlo Di Bonaventura; Anna Teresa Giallonardo; Alfredo Berardelli; Matteo Bologna
Journal:  Cerebellum       Date:  2020-11-16       Impact factor: 3.847

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.